Skip to main content

Table 2 Valid the promoting blood circulation activity of vinegars in vivo

From: Application of a strategy based on metabolomics guided promoting blood circulation bioactivity compounds screening of vinegar

Groups

WBV

PV

TT (s)

PT (s)

FIB (g L−1)

APTT (s)

ESR

PCV

1

3

30

100

200

N

11.06 ± 1.12

8.18 ± 1.15

4.69 ± 0.25

3.63 ± 0.19

3.16 ± 0.15

1.45 ± 0.06

28.77 ± 4.20

9.80 ± 0.30

1.76 ± 0.22

12.93 ± 0.94

0.62 ± 0.75

44.10 ± 3.17

M

23.52 ± 3.12**

13.51 ± 1.60**

6.25 ± 0.45**

4.76 ± 0.50**

3.85 ± 0.24**

1.66 ± 0.07**

24.60 ± 1.22*

8.50 ± 0.37**

5.59 ± 0.45**

10.07 ± 0.72**

2.83 ± 2.32**

51.87 ± 5.53**

W

28.74 ± 2.01

15.93 ± 0.96

6.23 ± 0.88

5.23 ± 0.20

4.18 ± 0.16

1.64 ± 0.03

36.88 ± 2.83##

8.92 ± 0.25

5.58 ± 0.44

14.26 ± 0.55#

1.72 ± 1.23

48.48 ± 2.85

RL

23.83 ± 2.85

13.30 ± 1.03

6.07 ± 0.33

4.48 ± 0.38

3.77 ± 0.17

1.52 ± 0.07##

40.88 ± 3.78##

9.15 ± 0.33##

5.41 ± 0.45

14.37 ± 1.07#

1.80 ± 1.15

50.66 ± 2.01

RH

23.70 ± 2.69

13.71 ± 1.14

6.10 ± 0.19

4.52 ± 0.32

3.78 ± 0.14

1.51 ± 0.06##

37.72 ± 3.45##

9.66 ± 0.35##

4.64 ± 0.32##

15.68 ± 1.41##

1.30 ± 1.12#

52.07 ± 3.09

AER

18.71 ± 2.54##

11.69 ± 1.52#

5.72 ± 0.35#

4.16 ± 0.22##

3.54 ± 0.20##

1.51 ± 0.05##

39.37 ± 4.98##

9.43 ± 0.51##

5.26 ± 0.66#

13.55 ± 1.29#

0.63 ± 0.73##

45.42 ± 3.22##

TMPZ

23.24 ± 2.80

13.57 ± 1.25

6.03 ± 0.42

4.47 ± 0.49

3.74 ± 0.21

1.57 ± 0.05#

35.12 ± 4.13##

9.02 ± 0.25#

5.54 ± 0.83

15.45 ± 0.55

1.00 ± 0.88#

47.98 ± 2.02

Asp

18.89 ± 1.70#

12.51 ± 1.27#

5.86 ± 0.26#

4.13 ± 0.07##

3.52 ± 0.10##

1.53 ± 0.10#

38.20 ± 2.01##

9.35 ± 0.44##

4.68 ± 0.34##

15.37 ± 0.81#

0.58 ± 0.88##

46.72 ± 3.93##

  1. Data represent mean ± SD n = 8
  2. N Normal group, M Model group, W WV group, RL RV low dosage group, RH RV high dosage group, AER0 Alkaloid extraction of RV
  3. * p < 0.05 vs. control group
  4. ** p < 0.01 vs. control group
  5. #p < 0.05 vs. model group
  6. ##p < 0.01 vs. model group